Most Recent
Generic drug maker Sandoz is challenging a ruling that it infringed a patent behind Lundbeck's blockbuster antidepressant Lexapro, reviving a 15-year fight over the lucrative intellectual property.
French pharmaceutical giant Sanofi has appealed a judge's ruling denying its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.
A barrister for two units of embattled wealth manager IOOF and three senior company executives facing claims by APRA have criticised the regulator for filing a broad concise statement and no statement of claim after a three-year investigation.
NSW Ports has criticised the Australian Competition and Consumer Commission for expecting the company to file a defence to the regulator's allegations of anti-competitive conduct from a concise statement it panned as "vague".
A judge has signed off on a $6.7 million settlement in a shareholder class action against mining firm MacMahon Holdings that will see group members get $2.4 million, or 35 per cent, of the total sum.
A shareholder class action led by Bannister Law against sandalwood oil producer Quintis will be absorbed by rival law firm Gadens in a consolidation agreement that ends a battle over the competing cases.
Shareholders who registered for a class action against mining company MacMahon Holdings will get a $2.4 million cut of a proposed $6.7 million settlement, according to a notice sent to group members ahead of next week's settlement approval hearing.
Fairfax is facing a defamation lawsuit from the former head of franchise giant Retail Food Group, who alleges a series of articles in the Sydney Morning Herald implied he engaged in dishonest business practices, including stealing property from former INXS frontman Michael Hutchence and associating with the mafia.
Generic drug maker Sandoz has been found liable for patent infringement and misleading and deceptive conduct in a case by pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro, ending a battle that has raged for 15 years.
Lawyers leading a class action against Quintis want the failed sandalwood oil producer to hand over evidence of any insurance policy that could cover the company and its founder for damages sought in the case.